CN Patent

CN1161112C — 含氯雷他定和伪麻黄碱的药物胶囊组合物

Assigned to Yuhan Corp · Expires 2004-08-11 · 22y expired

What this patent protects

本发明涉及口服药物胶囊组合物，它包含：含氯雷他定和伪麻黄碱或其药物上可接受的盐的快速释放丸(丸A)与含伪麻黄碱或其药物上可接受的盐的缓释丸(丸B)，其中，丸B被涂布了水不溶性聚合物和阻湿剂。

USPTO Abstract

本发明涉及口服药物胶囊组合物，它包含：含氯雷他定和伪麻黄碱或其药物上可接受的盐的快速释放丸(丸A)与含伪麻黄碱或其药物上可接受的盐的缓释丸(丸B)，其中，丸B被涂布了水不溶性聚合物和阻湿剂。

Drugs covered by this patent

amantadine-hydrochloride (AMANTADINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN1161112C
Jurisdiction: CN
Classification: —
Expires: 2004-08-11
Drug substance claim: No
Drug product claim: No
Assignee: Yuhan Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.